Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride may be linked to Peyronie’s disease, but more research is needed.

Taking high doses of Cyproterone acetate significantly increases the risk of meningioma in females.

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

The botanical treatment for hair loss shows promise, especially for children.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Europe strengthened medicine regulations, increased protection against counterfeit drugs, and made it tougher to challenge comparative advertising, while also focusing on patent law enforcement and updating plant protection rules.

The document concludes that "Dictamnus" has a rich cultural history and potential as a herbal medicine, warranting more research into its effects and safety.

Using electronic health records can help identify drug side effects but has some limitations.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Bioassays help find useful compounds in nature for making medicines, supplements, and cosmetics.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

St. John's wort increases finasteride metabolism, reducing its effectiveness; use caution when combining them.

New drugs and combination therapies are improving treatment for lower urinary tract symptoms.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Formononetin, found in red clover, may treat hair loss with fewer side effects.

Terbinafine is the most effective medicine for fungal nail infections, especially for diabetics and those with weak immune systems.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Multiple treatments work best for hair loss.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

New treatments for male hair loss show promise but need more research for safety and effectiveness.